Writing.io Jobs

Your work will change lives. Including your own.

The Impact You’ll Make

At Recursion, we are decoding biology to radically improve lives. As Vice President, Medical Affairs, you will help shape how Recursion translates breakthrough science, clinical data, real-world evidence, and AI-enabled insights into meaningful impact for patients, clinicians, investigators, and health systems.

You will build and lead the Medical Affairs strategy across Recursion’s advancing clinical portfolio, with an initial focus on programs in areas of significant unmet need, including oncology, rare disease, immunology, and other priority therapeutic areas. This is a high-impact, cross-functional leadership role for a strategic medical affairs leader who can operate from early development through launch readiness, bring the external medical voice into portfolio decisions, and establish scalable capabilities for scientific engagement, evidence generation, medical communications, and medical excellence.

In this role, you will:

• Develop and lead integrated Medical Affairs strategies for priority assets, including scientific narrative, evidence gaps, stakeholder engagement, publication strategy, medical education, advisory boards, field medical planning, and launch readiness.
• Provide Medical Affairs support on cross-functional asset teams, partnering with Clinical Development, Regulatory Affairs, Development Sciences, HEOR/RWE, Biostatistics, Clinical Operations, Portfolio Strategy, Patient Advocacy, Communications, Legal/Compliance, and Business Development, where appropriate.
• Build evidence-generation plans that support asset differentiation, patient benefit, clinical adoption, and value demonstration, including real-world evidence, HEOR, epidemiology, natural history, burden of disease, treatment patterns, and outcomes-focused studies.
• Translate external insights from healthcare professionals, investigators, patient communities, payers, health systems, and scientific leaders into actionable recommendations for development strategy, trial design, endpoints, education needs, and evidence priorities.
• Lead scientific engagement strategy with key opinion leaders, digital opinion leaders, investigators, cooperative groups, patient advocacy organizations, professional societies, and other external stakeholders through compliant, high-quality scientific exchange.
• Lead congress and conference strategy for priority programs, including planning and execution for major scientific meetings such as ASCO, ESMO, AACR, AAN, and other relevant medical congresses; partner cross-functionally on abstracts, presentations, scientific narratives, medical booths, KOL engagement, and internal preparation.
• Partner with Recursion’s data science, platform, and Decision Science teams to explore responsible use of AI-enabled approaches for medical insights, evidence synthesis, stakeholder mapping, scientific communication, and measurement of medical impact.
• Establish the medical communication strategy for assigned assets, including publications, congress abstracts and presentations, lexicon, scientific platform, FAQs, medical information content, and internal scientific training.
• As the portfolio matures, design and build a structured, scalable Medical Affairs organization, including fit-for-purpose capabilities across medical strategy, field medical, medical communications, medical information, evidence generation, congress planning, insights, and medical excellence.
• Establish governance, operating rhythms, vendor partnerships, performance metrics, and compliant processes that enable Medical Affairs to support Recursion’s growth from clinical-stage development through potential launch readiness.

The Team You’ll Join

You will join Recursion’s Clinical Development organization, reporting to the Chief Medical Officer. The Clinical Development team is an empowered, execution-minded group responsible for translating Recursion’s innovative science into medicines for patients.

You will work closely with leaders across Development, Regulatory, Development Sciences, Clinical Operations, Data Science, Biology, Chemistry, Portfolio Strategy, Communications, Legal/Compliance, and future commercialization functions. Together, you will help ensure Recursion’s clinical programs are informed by robust evidence, external medical insight, patient need, and the full potential of the RecursionOS.

The Experience You’ll Need

• Advanced clinical or scientific degree required; MD, DO, PharmD, PhD, or equivalent advanced degree strongly preferred
• 15+ years of biotech or pharmaceutical industry experience, including significant leadership experience in Medical Affairs
• Experience building and leading Medical Affairs strategy for clinical-stage or launch-stage assets, ideally in oncology, rare disease, immunology, or other specialty therapeutic areas.
• Proven ability to lead integrated evidence planning, including RWE, HEOR, epidemiology, burden-of-disease, natural history, treatment-pattern, outcomes, and value-focused studies
• Strong understanding of drug development from early clinical development through launch readiness and lifecycle planning, including how Medical Affairs contributes to trial design, endpoint strategy, external engagement, publications, and evidence generation.
• Demonstrated success in engaging KOLs, investigators, patient advocacy organizations, professional societies, payers/HTA stakeholders, and other external experts through compliant scientific exchange.
• Experience developing scientific platforms, publication plans, congress strategies, advisory boards, medical education initiatives, and medical information resources.
• Strong working knowledge of relevant compliance expectations, including scientific exchange, medical review, publication practices, advisory board governance, and interactions with healthcare professionals across the US & globally

Working Location & Compensation:

This is a fully remote opportunity with occasional travel requirements. Travel may be necessary from time to time to support collaboration, team events, customer meetings, or other business needs.

At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is:

• New York City, Boston, & San Francisco Bay Area(s): $358,930–$449,240
• Salt Lake City & all other U.S. locations: $326,300–$408,400

In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.

#LI-DB1

#LI-REMOTE

The Values We Hope You Share:

• We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
• We care deeply and engage directly. Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
• We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
• We move with urgency because patients are waiting. Speed isn’t about rushing but about moving the needle every day.
• We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
• We are One Recursion. True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.

More About Recursion

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.

Recursion is an Equal Opportunity Employer.  All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.

Accommodations are available on request for candidates taking part in all aspects of the selection process.

Recursion leverages AI in our hiring process. We use Greenhouse’s Talent Matching AI technology feature to help review applications against the skills and experience we’ve identified as important for this role. It analyzes your resume and application responses to assess how closely your qualifications match our criteria - but all decisions are made by our human recruiters and hiring managers, including whether to move to the next phase of review. Talent Matching does not automatically advance or reject any candidate. By submitting your application, you acknowledge that you have been informed about and consent to this use of the Talent Matching tool in our review process. Please refer to our Recursion Privacy Policy at https://www.recursion.com/privacy-notice/ for more information about our processing of personal data and your rights.

Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.

Your work will change lives. Including your own.

The Impact You’ll Make

As the Recursion clinical asset pipeline continues to mature through key inflection points, the advancing assets require leaders who can translate scientific complexity into strategic clarity.  In the role of Executive Director, Asset Team Lead, you will drive the strategic positioning of assets, ensuring that decisioning is grounded in competitive reality, differentiated by Recursion OS insights, and built to move with urgency for patient benefit. You will play a pivotal role ensuring advanced computational approaches and proprietary Recursion OS/ClinTech advantages are leveraged across the portfolio continuum, redefining traditional paradigms of drug development.  Working across functional lines, you will partner with preclinical, clinical and platform teams, promoting communication, alignment and optimization of functional processes to ensure delivery of portfolio goals & transformative medicines for patients.

In this role, you will:

• Define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation — integrating competitive positioning, mechanistic differentiation, biomarker strategy, and patient segmentation to sharpen go/no-go and prioritization decisions across the portfolio
• Translate Recursion OS and ClinTech insights into strategic asset advantages, ensuring proprietary data and computational insights are maximally enabling for advancement of the drug discovery and development portfolio
• Develop and pressure-test the competitive narrative for each oncology and I&I portfolio asset, building the evidence base that will inform leadership decisions, partnering discussions and investor communications
• Partner with functional line leaders across clinical development, BD, finance and platform teams to ensure resource allocation reflects strategic conviction and supports the most impactful programs and workstreams
• Propagate the Recursion mindset of radically changing lives by continuously raising the bar on how assets are advanced, differentiated, and delivered to patients with significant unmet need

The Team You’ll Join

As an Executive Director, Asset Team Lead, you will work across the asset portfolio, operating as a senior strategic partner to leaders in Clinical Development, Discovery, ClinTech, Platform and BD. The Portfolio Team is execution-minded and analytically rigorous — fluent in both science and AI — and responsible for industrializing Recursion’s innovative science to advance medicines that matter. We break traditional silos, leveraging AI-powered platforms across data analysis, predictive modeling, RWE integration and patient stratification, all with the goal of optimizing asset positioning for the greatest benefit to patients.

The Experience You’ll Need

• A PhD in life sciences or related scientific discipline with deep expertise in drug discovery & development required
• 10+ years of biotech/pharma experience with a proven track record of asset-level strategic leadership, advancing programs through clinical stage-gates with demonstrable impact on portfolio value
• Deep expertise in the development of small molecule therapeutics for oncology and immunology/inflammation required, expertise in rare disease a bonus
• Experience leveraging computational approaches and data-driven platforms to sharpen asset strategy and clinical decision-making
• Proven ability to build and articulate the strategic and competitive case for clinical assets – integrating mechanistic differentiation, competitive dynamics, regulatory and market considerations.
• Strong financial acumen; able to engage credibly on cross-functional resourcing, asset valuation, and portfolio trade-offs
• Exceptional executive presence – able to synthesize complexity into clear, conviction-led recommendations and present with confidence to senior leadership and external partners

Working Location & Compensation:

This is a remote position based in the United States with required periodic travel. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.

#LI-EP1

#LI-REMOTE

The Values We Hope You Share:

• We act boldly with integrity. We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
• We care deeply and engage directly. Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
• We learn actively and adapt rapidly. Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
• We move with urgency because patients are waiting. Speed isn’t about rushing but about moving the needle every day.
• We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
• We are One Recursion. True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.

More About Recursion

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.

Recursion is an Equal Opportunity Employer.  All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.

Accommodations are available on request for candidates taking part in all aspects of the selection process.

Recursion leverages AI in our hiring process. We use Greenhouse’s Talent Matching AI technology feature to help review applications against the skills and experience we’ve identified as important for this role. It analyzes your resume and application responses to assess how closely your qualifications match our criteria - but all decisions are made by our human recruiters and hiring managers, including whether to move to the next phase of review. Talent Matching does not automatically advance or reject any candidate. By submitting your application, you acknowledge that you have been informed about and consent to this use of the Talent Matching tool in our review process. Please refer to our Recursion Privacy Policy at https://www.recursion.com/privacy-notice/ for more information about our processing of personal data and your rights.

Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.

Your Future Evolves HereEvolent partners with health plans and providers to achieve better outcomes for people with most complex and costly health conditions.

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases.